Anti-SARS-CoV-2 immunoglobulin (D'Or Institute for Research and Education)

N/A

Report date: 2024/11/23 20:00:08

Base Information

Drug NameAnti-SARS-CoV-2 immunoglobulin (D'Or Institute for Research and Education)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesD'Or Institute For Research And Education
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesD'Or Institute For Research And Education
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A